SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort
Abstract Euglycemic diabetic ketoacidosis (EuDKA) secondary to Sodium-glucose co-transporter-2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported phenomenon. Not much is known about the burden of EuDKA in patients on SGLT2i or the associated factors. This retro...
Guardado en:
Autores principales: | Fateen Ata, Zohaib Yousaf, Adeel Ahmad Khan, Almurtada Razok, Jaweria Akram, Elrazi Awadelkarim Hamid Ali, Ahmed Abdalhadi, Diaeldin Abdelgalil Ibrahim, Dabia Hamad S. H. Al Mohanadi, Mohammed I. Danjuma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c11be729c4a4190bbabeae68c63aca0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats
por: Rachel J. Perry, et al.
Publicado: (2019) -
Comparing the Efficacy of a Nurse-Driven and a Physician-Driven Diabetic Ketoacidosis (DKA) Treatment Protocol
por: Anis TR, et al.
Publicado: (2021) -
Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjects
por: Shin D, et al.
Publicado: (2019) -
Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis
por: Clara M. Gomez-Sanchez, MD, et al.
Publicado: (2021) -
Treatment outcome and prognostic indices in patients with hyperglycemic emergencies
por: Ezeani IU, et al.
Publicado: (2013)